Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Employment (1)

Medical University of Vienna: Vienna, AT

(Department of Medicine III, Division of Rheumatology)
Employment
Source: Self-asserted source
Andreas Kerschbaumer

Works (50 of 51)

Items per page:
Page 1 of 2

Definition of rheumatoid arthritis flare based on SDAI and CDAI

Annals of the Rheumatic Diseases
2024 | Journal article
DOI: 10.1136/ARD-2023-224742
WOSUID: WOS:001098304800001
Contributors: Konzett, Victoria; Kerschbaumer, Andreas; Smolen, Josef S.; Kristianslund, Eirik Klami; Provan, Sella A.; Kvien, Tore K.; Aletaha, Daniel
Source: check_circle
Web of Science Researcher Profile Sync

Determination of the most appropriate ACR response definition for contemporary drug approval trials in rheumatoid arthritis

Annals of the Rheumatic Diseases
2024 | Journal article
DOI: 10.1136/ARD-2023-224477
WOSUID: WOS:001072672800001
Contributors: Konzett, Victoria; Kerschbaumer, Andreas; Smolen, Josef S.; Aletaha, Daniel
Source: check_circle
Web of Science Researcher Profile Sync

Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review

Rheumatology
2024 | Journal article
DOI: 10.1093/RHEUMATOLOGY/KEAD471
WOSUID: WOS:001069837300001
Contributors: Hysa, Elvis; Bond, Milena; Ehlers, Lisa; Camellino, Dario; Falzon, Louise; Dejaco, Christian; Buttgereit, Frank; Aletaha, Daniel; Kerschbaumer, Andreas
Source: check_circle
Web of Science Researcher Profile Sync

Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story

Annals of the Rheumatic Diseases
2024 | Journal article
DOI: 10.1136/ARD-2023-223850
WOSUID: WOS:001096418100001
Contributors: Bonelli, Michael; Kerschbaumer, Andreas; Kastrati, Kastriot; Ghoreschi, Kamran; Gadina, Massimo; Heinz, Leonhard X.; Smolen, Josef S.; Aletaha, Daniel; O'Shea, John; Laurence, Arian
Source: check_circle
Web of Science Researcher Profile Sync

Treat-to-target recommendations in giant cell arteritis and polymyalgia rheumatica

Annals of the Rheumatic Diseases
2024 | Journal article
DOI: 10.1136/ARD-2022-223429
WOSUID: WOS:000951185300001
Contributors: Dejaco, Christian; Kerschbaumer, Andreas; Aletaha, Daniel; Bond, Milena; Hysa, Elvis; Camellino, Dario; Ehlers, Lisa; Abril, Andy; Appenzeller, Simone; Cid, Maria C. et al.
Source: check_circle
Web of Science Researcher Profile Sync

Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls

Annals of the Rheumatic Diseases
2023 | Journal article
DOI: 10.1136/ARD-2022-222682
WOSUID: WOS:000855282300001
Contributors: Kartnig, Felix; Mrak, Daniel; Simader, Elisabeth; Tobudic, Selma; Radner, Helga; Mandl, Peter; Goeschl, Lisa; Hommer, Nikolaus; Mayer, Margareta; Hofer, Philipp et al.
Source: check_circle
Web of Science Researcher Profile Sync

Influence of active versus placebo control on treatment responses in randomised controlled trials in rheumatoid arthritis

Annals of the Rheumatic Diseases
2023-01-10 | Journal article | Author
DOI: 10.1136/ard-2022-223349
Part of ISSN: 0003-4967
Part of ISSN: 1468-2060
Contributors: Andreas Kerschbaumer; Nina Maria Stimakovits; Josef Smolen; Tijen Stefanova; Eva Chwala; Daniel Aletaha
Source: Self-asserted source
Andreas Kerschbaumer
grade
Preferred source (of 2)‎

A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS INTO THE SUCCESS RATE OF GLUCOCORTICOID DISCONTINUATION AFTER THEIR USE AS INITIAL BRIDGING THERAPY IN RHEUMATOID ARTHRITIS PATIENTS IN OBSERVATIONAL COHORTS AND CLINICAL TRIALS

Annals of the Rheumatic Diseases
2022 | Journal article
DOI: 10.1136/ANNRHEUMDIS-2022-EULAR.1969
WOSUID: WOS:000850279005258
Contributors: Van Ouwerkerk, L.; Palmowski, A.; Nevins, I.; Buttgereit, F.; Verschueren, P.; Smolen, J.; Landewe, R. B. M.; Bijlsma, H.; Kerschbaumer, A.; Westhovens, R. et al.
Source: check_circle
Web of Science Researcher Profile Sync

Fourth SARS-CoV-2 Vaccine Dose in Rituximab Treated Patients: An Open Label Extension Study

Arthritis & Rheumatology
2022 | Journal article
WOSUID: WOS:000877386501218
Contributors: Mrak, Daniel; Simader, Elisabeth; Sieghart, Daniela; Mandl, Peter; Radner, Helga; Perkmann, Thomas; Haslacher, Helmuth; Mayer, Margareta; Koblischke, Maximilian; Hofer, Philipp et al.
Source: check_circle
Web of Science Researcher Profile Sync

Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial

Nature Communications
2022 | Journal article
DOI: 10.1038/S41467-022-33036-Y
WOSUID: WOS:000853182100002
Contributors: Mrak, Daniel; Sieghart, Daniela; Simader, Elisabeth; Tobudic, Selma; Radner, Helga; Mandl, Peter; Goeschl, Lisa; Koblischke, Maximilian; Hommer, Nikolaus; Wagner, Angelika et al.
Source: check_circle
Web of Science Researcher Profile Sync

Heterologous Vector versus Homologous mRNA COVID-19 Booster Vaccination in Non-seroconverted Immunosuppressed Patients: A Randomized Controlled Trial

Arthritis & Rheumatology
2022 | Journal article
WOSUID: WOS:000877386501285
Contributors: Sieghart, Daniela; Mrak, Daniel; Simader, Elisabeth; Tobudic, Selma; Radner, Helga; Mandl, Peter; Goschl, Lisa; Koblischke, Maximilian; Hommer, Nikolaus; Hartl, Lukas et al.
Source: check_circle
Web of Science Researcher Profile Sync

Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study

Annals of the Rheumatic Diseases
2022 | Journal article
DOI: 10.1136/ARD-2022-222579
WOSUID: WOS:000841779900001
Contributors: Mrak, Daniel; Simader, Elisabeth; Sieghart, Daniela; Mandl, Peter; Radner, Helga; Perkmann, Thomas; Haslacher, Helmuth; Mayer, Margareta; Koblischke, Maximilian; Hofer, Philipp et al.
Source: check_circle
Web of Science Researcher Profile Sync

Intercepting psoriatic arthritis in patients with psoriasis: buy one get one free?

Annals of the Rheumatic Diseases
2022 | Journal article
DOI: 10.1136/ANNRHEUMDIS-2021-221255
WOSUID: WOS:000721841200001
Contributors: McGonagle, Dennis G.; Zabotti, Alen; Watad, Abdulla; Bridgewood, Charlie; De Marco, Gabriele; Kerschbaumer, Andreas; Aletaha, Daniel
Source: check_circle
Web of Science Researcher Profile Sync

Perceptions and experiences of individuals at-risk of rheumatoid arthritis (RA) knowing about their risk of developing RA and being offered preventive treatment: systematic review and thematic synthesis of qualitative studies

Annals of the Rheumatic Diseases
2022 | Journal article
DOI: 10.1136/ANNRHEUMDIS-2021-221160
WOSUID: WOS:000721858900001
Contributors: Siddle, Heidi J.; Chapman, Lara S.; Mankia, Kulveer; Zabalan, Codruta; Kouloumas, Marios; Raza, Karim; Falahee, Marie; Kerry, Joel; Kerschbaumer, Andreas; Aletaha, Daniel et al.
Source: check_circle
Web of Science Researcher Profile Sync

Segmental endobronchial valve therapy for a vasculitis-induced emphysema

Respiratory Medicine Case Reports
2022 | Journal article
DOI: 10.1016/J.RMCR.2022.101650
WOSUID: WOS:000790314900001
Contributors: Bal, Christina; Goeschl, Lisa; Milos, Ruxandra-Iulia; Gerstbrein, Klaus; Kerschbaumer, Andreas; Idzko, Marco; Gompelmann, Daniela
Source: check_circle
Web of Science Researcher Profile Sync

Systematic literature review of observational cohorts and clinical trials into the success rate of glucocorticoid discontinuation after their use as bridging therapy in patients with rheumatoid arthritis

Annals of the Rheumatic Diseases
2022 | Journal article
DOI: 10.1136/ANNRHEUMDIS-2022-222338
WOSUID: WOS:000788203700001
Contributors: van Ouwerkerk, Lotte; Palmowski, Andriko; Nevins, Isabell S.; Buttgereit, Frank; Verschueren, Patrick; Smolen, Josef S.; Landewe, Robert B. M.; Bijlsma, Johannes J. W.; Kerschbaumer, Andreas; Westhovens, Rene et al.
Source: check_circle
Web of Science Researcher Profile Sync

Which ACR Response Definition Should Be Used for Disease Activity Claims in Approval Studies of Rheumatoid Arthritis? A Systematic Evaluation

Arthritis & Rheumatology
2022 | Journal article
WOSUID: WOS:000877386505214
Contributors: Kerschbaumer, Andreas; Konzett, Victoria; Smolen, Josef; Aletaha, Daniel
Source: check_circle
Web of Science Researcher Profile Sync

Efficacy, duration of use and safety of glucocorticoids: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.

Annals of the rheumatic diseases
2022-11-21 | Journal article | Author
DOI: 10.1136/ard-2022-223358
PMID: 36410794
Contributors: Sytske Anne Bergstra; Alexandre Sepriano; Andreas Kerschbaumer; Désirée van der Heijde; Caporali R; Edwards CJ; Patrick Verschueren; 0000-0003-4953-3257; Janet Pope; Tsutomu Takeuchi et al.
Source: Self-asserted source
Andreas Kerschbaumer
grade
Preferred source (of 2)‎

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.

Annals of the rheumatic diseases
2022-11-14 | Journal article | Author
DOI: 10.1136/ard-2022-223357
PMID: 36376026
Contributors: Alexandre Sepriano; Andreas Kerschbaumer; Sytske Anne Bergstra; Josef Smolen; Désirée van der Heijde; Caporali R; Edwards CJ; Patrick Verschueren; 0000-0003-4953-3257; Janet Pope et al.
Source: Self-asserted source
Andreas Kerschbaumer
grade
Preferred source (of 2)‎

Efficacy of synthetic and biological DMARDs: a systematic literature review informing the 2022 update of the EULAR recommendations for the management of rheumatoid arthritis.

Annals of the rheumatic diseases
2022-11-11 | Journal article | Author
DOI: 10.1136/ard-2022-223365
PMID: 36368906
Contributors: Andreas Kerschbaumer; Alexandre Sepriano; Sytske Anne Bergstra; Smolen JS; Désirée van der Heijde; Caporali R; Edwards CJ; Patrick Verschueren; 0000-0003-4953-3257; Janet Pope et al.
Source: Self-asserted source
Andreas Kerschbaumer
grade
Preferred source (of 2)‎

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update.

Annals of the rheumatic diseases
2022-11-10 | Journal article | Author
DOI: 10.1136/ard-2022-223356
PMID: 36357155
Contributors: Josef Smolen; Robert Landewé; Sytske Anne Bergstra; Andreas Kerschbaumer; Alexandre Sepriano; Daniel Aletaha; Caporali R; Edwards CJ; Kimme Hyrich; Janet Pope et al.
Source: Self-asserted source
Andreas Kerschbaumer
grade
Preferred source (of 3)‎

Impact of pre-existing background therapy on placebo responses in randomised controlled clinical trials of rheumatoid arthritis

Annals of the Rheumatic Diseases
2022-10 | Journal article | Author
DOI: 10.1136/annrheumdis-2021-221807
Part of ISSN: 0003-4967
Part of ISSN: 1468-2060
Contributors: Andreas Kerschbaumer; Zaïda Iasha Rivai; Josef S Smolen; Daniel Aletaha
Source: Self-asserted source
Andreas Kerschbaumer
grade
Preferred source (of 2)‎

A systematic literature review informing the consensus statement on efficacy and safety of pharmacological treatment with interleukin-6 pathway inhibition with biological DMARDs in immune-mediated inflammatory diseases.

RMD open
2022-09-01 | Journal article | Author
DOI: 10.1136/rmdopen-2022-002359
PMID: 36260501
PMC: PMC9462104
Contributors: Kastriot Kastrati; Daniel Aletaha; Gerd-Rüdiger Burmester; Chwala E; Christian Dejaco; maxime dougados; Iain McInnes; ANGELO RAVELLI; Sattar N; Tanja Stamm et al.
Source: Self-asserted source
Andreas Kerschbaumer
grade
Preferred source (of 2)‎

Consensus statement on blocking interleukin-6 receptor and interleukin-6 in inflammatory conditions: an update.

Annals of the rheumatic diseases
2022-08-11 | Journal article | Author
DOI: 10.1136/ard-2022-222784
PMID: 35953263
Contributors: Daniel Aletaha; Andreas Kerschbaumer; Kastriot Kastrati; Christian Dejaco; maxime dougados; McInnes IB; Sattar N; Tanja Stamm; Tsutomu Takeuchi; Michael Trauner et al.
Source: Self-asserted source
Andreas Kerschbaumer
grade
Preferred source (of 2)‎

Torque Teno Virus quantification for monitoring of immunomodulation with biologic compounds in the treatment of rheumatoid arthritis.

Rheumatology (Oxford, England)
2022-07-01 | Journal article
DOI: 10.1093/rheumatology/keab839
PMID: 34792562
Contributors: Paul Studenic; gregor bond; Kerschbaumer A; Bécède M; Pavelka K; Karateev D; Stieger J; Puchner R; Mueller RB; Puchhammer-Stöckl E et al.
Source: Self-asserted source
Andreas Kerschbaumer
grade
Preferred source (of 2)‎

Tocilizumab in patients with new onset polymyalgia rheumatica (PMR-SPARE): a phase 2/3 randomised controlled trial.

Annals of the rheumatic diseases
2022-02-24 | Journal article | Author
DOI: 10.1136/annrheumdis-2021-221126
PMID: 35210264
Contributors: Michael Bonelli; Radner H; Andreas Kerschbaumer; Daniel Mrak; Durechova M; Stieger J; Husic R; Peter Mandl; Smolen JS; Christian Dejaco et al.
Source: Self-asserted source
Andreas Kerschbaumer
grade
Preferred source (of 2)‎

Dr. Andreas Kerschbaumer is Researcher of the Month January 2021

Wiener Klinische Wochenschrift
2021 | Journal article
DOI: 10.1007/S00508-021-01808-Z
WOSUID: WOS:000612367500011
Contributors: Kerschbaumer, Andreas
Source: check_circle
Web of Science Researcher Profile Sync

What Is the Success Rate in Clinical Trials of Discontinuation Glucocorticoids After Their Use as Bridging Therapy - a Systematic Literature Review

Arthritis & Rheumatology
2021 | Journal article
WOSUID: WOS:000744545203097
Contributors: van Ouwerkerk, Lotte; Nevins, Isabell; Verschueren, Patrick; Smolen, Josef; Landewe, Robert; Bijlsma, Johannes; Kerschbaumer, Andreas; Huizinga, Tom W. J.; Westhovens, Rene; Allaart, Cornelia F. et al.
Source: check_circle
Web of Science Researcher Profile Sync

A core set of risk factors in individuals at risk of rheumatoid arthritis: a systematic literature review informing the EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis.

RMD open
2021-09 | Journal article
DOI: 10.1136/rmdopen-2021-001768
PMID: 34531306
PMC: PMC8449955
Contributors: Mankia K; Siddle H; Di Matteo A; Alpízar-Rodríguez D; Kerry J; Kerschbaumer A; Aletaha D; Emery P
Source: Self-asserted source
Andreas Kerschbaumer via Europe PubMed Central
grade
Preferred source (of 2)‎

EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis.

Annals of the rheumatic diseases
2021-08 | Journal article
DOI: 10.1136/annrheumdis-2021-220884
PMID: 34362746
PMC: PMC8458095
Contributors: Mankia K; Siddle HJ; Kerschbaumer A; Alpizar Rodriguez D; Catrina AI; Cañete JD; Cope AP; Daien CI; Deane KD; El Gabalawy H et al.
Source: Self-asserted source
Andreas Kerschbaumer via Europe PubMed Central
grade
Preferred source (of 2)‎

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a consensus statement.

Annals of the rheumatic diseases
2020-11 | Journal article
DOI: 10.1136/annrheumdis-2020-218398
PMID: 33158881
PMC: PMC7788060
Contributors: Nash P; Kerschbaumer A; Dörner T; Dougados M; Fleischmann RM; Geissler K; McInnes I; Pope JE; van der Heijde D; Stoffer-Marx M et al.
Source: Self-asserted source
Andreas Kerschbaumer via Europe PubMed Central
grade
Preferred source (of 2)‎

Points to consider for the treatment of immune-mediated inflammatory diseases with Janus kinase inhibitors: a systematic literature research.

RMD open
2020-11 | Journal article
DOI: 10.1136/rmdopen-2020-001374
PMID: 33188136
PMC: PMC7856126
Contributors: Kerschbaumer A; Smolen JS; Nash P; Doerner T; Dougados M; Fleischmann R; Geissler K; McInnes IB; Takeuchi T; Trauner M et al.
Source: Self-asserted source
Andreas Kerschbaumer via Europe PubMed Central
grade
Preferred source (of 2)‎

Hand X-ray examination in two planes is not required for radiographic assessment of hand osteoarthritis.

Therapeutic advances in musculoskeletal disease
2020-07 | Journal article
DOI: 10.1177/1759720x20934934
PMID: 32655702
PMC: PMC7333491
Contributors: Staats K; Sunk IG; Weidekamm C; Kerschbaumer A; Bécède M; Supp G; Stamm T; Windhager R; Smolen JS; Bobacz K
Source: Self-asserted source
Andreas Kerschbaumer via Europe PubMed Central
grade
Preferred source (of 2)‎

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update.

Annals of the rheumatic diseases
2020-06-01 | Journal article | Author
DOI: 10.1136/annrheumdis-2020-217159
PMID: 32434812
PMC: PMC7286048
Contributors: Laure Gossec; Baraliakos X; Andreas Kerschbaumer; Maarten de Wit; McInnes I; Dougados M; Jette Primdahl; McGonagle DG; Aletaha D; Balanescu A et al.
Source: Self-asserted source
Andreas Kerschbaumer
grade
Preferred source (of 3)‎

Is Methotrexate as Efficacious as Etanercept in Psoriatic Arthritis Patients? Comment on the Article by Mease et al.

Arthritis & rheumatology (Hoboken, N.J.)
2020-05 | Journal article
DOI: 10.1002/art.41274
PMID: 32336032
Contributors: Kerschbaumer A; Smolen JS; Aletaha D
Source: Self-asserted source
Andreas Kerschbaumer via Europe PubMed Central
grade
Preferred source (of 2)‎

Pharmacological treatment of psoriatic arthritis: a systematic literature research for the 2019 update of the EULAR recommendations for the management of psoriatic arthritis.

Annals of the rheumatic diseases
2020-05 | Journal article
DOI: 10.1136/annrheumdis-2020-217163
PMID: 32381564
Contributors: Kerschbaumer A; Smolen JS; Dougados M; de Wit M; Primdahl J; McInnes I; van der Heijde D; Baraliakos X; Falzon L; Gossec L
Source: Self-asserted source
Andreas Kerschbaumer via Europe PubMed Central
grade
Preferred source (of 2)‎

Efficacy outcomes in phase 2 and phase 3 randomized controlled trials in rheumatology.

Nature medicine
2020-04 | Journal article
DOI: 10.1038/s41591-020-0833-4
PMID: 32313250
Contributors: Kerschbaumer A; Smolen JS; Herkner H; Stefanova T; Chwala E; Aletaha D
Source: Self-asserted source
Andreas Kerschbaumer via Europe PubMed Central
grade
Preferred source (of 2)‎

Targeting p19 in psoriatic arthritis: more than just another therapeutic approach?

Lancet (London, England)
2020-03 | Journal article
DOI: 10.1016/s0140-6736(20)30525-0
PMID: 32178770
Contributors: Kerschbaumer A; Aletaha D
Source: Self-asserted source
Andreas Kerschbaumer via Europe PubMed Central
grade
Preferred source (of 2)‎

Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis.

Annals of the rheumatic diseases
2020-02 | Journal article
DOI: 10.1136/annrheumdis-2019-216656
PMID: 32033937
PMC: PMC7286044
Contributors: Kerschbaumer A; Sepriano A; Smolen JS; van der Heijde D; Dougados M; van Vollenhoven R; McInnes IB; Bijlsma JWJ; Burmester GR; de Wit M et al.
Source: Self-asserted source
Andreas Kerschbaumer via Europe PubMed Central
grade
Preferred source (of 2)‎

Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritis.

Annals of the rheumatic diseases
2020-02 | Journal article
DOI: 10.1136/annrheumdis-2019-216653
PMID: 32033941
Contributors: Sepriano A; Kerschbaumer A; Smolen JS; van der Heijde D; Dougados M; van Vollenhoven R; McInnes IB; Bijlsma JW; Burmester GR; de Wit M et al.
Source: Self-asserted source
Andreas Kerschbaumer via Europe PubMed Central
grade
Preferred source (of 2)‎

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update.

Annals of the rheumatic diseases
2020-01 | Journal article
DOI: 10.1136/annrheumdis-2019-216655
PMID: 31969328
Contributors: Smolen JS; Landewé RBM; Bijlsma JWJ; Burmester GR; Dougados M; Kerschbaumer A; McInnes IB; Sepriano A; van Vollenhoven RF; de Wit M et al.
Source: Self-asserted source
Andreas Kerschbaumer via Europe PubMed Central
grade
Preferred source (of 2)‎

Efficacy and Safety of Disease-Modifying Drugs in Psoriatic Arthritis (PsA): A Systematic Literature Review

Arthritis & Rheumatology
2019 | Journal article
WOSUID: WOS:000507466904256
Contributors: Kerschbaumer, Andreas; Smolen, Josef; Dougados, Maxime; de Wit, Maarten; Primdahl, Jette; McInnes, Iain; van der Heijde, Desiree; Falzon, Louise; Baraliakos, Xenofon; Gossec, Laure
Source: check_circle
Web of Science Researcher Profile Sync

Efficacy of Pharmacological Treatment in Rheumatoid Arthritis: A Systematic Literature Review Informing the 2019 Update of the EULAR Recommendations for Management of Rheumatoid Arthritis

Arthritis & Rheumatology
2019 | Journal article
WOSUID: WOS:000507466902266
Contributors: Kerschbaumer, Andreas; Sepriano, Alexandre; Smolen, Josef; van der Heijde, Desiree; Dougados, Maxime; Van Vollenhoven, Ronald F.; McInnes, Iain; Bijlsma, Johannes; Burmester, Gerd; de Wit, Maarten et al.
Source: check_circle
Web of Science Researcher Profile Sync

Safety of Synthetic and Biological DMARDs: A Systematic Literature Review Informing the 2019 Update of the EULAR Recommendations for Management of Rheumatoid Arthritis

Arthritis & Rheumatology
2019 | Journal article
WOSUID: WOS:000507466901273
Contributors: Sepriano, Alexandre; Kerschbaumer, Andreas; Smolen, Josef; van der Heijde, Desiree; Dougados, Maxime; Van Vollenhoven, Ronald F.; McInnes, Iain; Bijlsma, Johannes; Burmester, Gerd; de Wit, Maarten et al.
Source: check_circle
Web of Science Researcher Profile Sync

Risk profiling for a refractory course of rheumatoid arthritis.

Seminars in arthritis and rheumatism
2019-02 | Journal article
DOI: 10.1016/j.semarthrit.2019.02.004
PMID: 30799033
Contributors: Bécède M; Alasti F; Gessl I; Haupt L; Kerschbaumer A; Landesmann U; Loiskandl M; Supp GM; Smolen JS; Aletaha D
Source: Self-asserted source
Andreas Kerschbaumer via Europe PubMed Central
grade
Preferred source (of 2)‎

Disease activity assessment in patients with psoriatic arthritis.

Best practice & research. Clinical rheumatology
2018-06 | Journal article
DOI: 10.1016/j.berh.2018.08.004
PMID: 31171311
Contributors: Kerschbaumer A; Smolen JS; Aletaha D
Source: Self-asserted source
Andreas Kerschbaumer via Europe PubMed Central
grade
Preferred source (of 2)‎

Tofacitinib for Psoriatic Arthritis.

The New England journal of medicine
2018-02 | Journal article
DOI: 10.1056/nejmc1715189
PMID: 29469555
Contributors: Aletaha D; Kerschbaumer A; Smolen JS
Source: Self-asserted source
Andreas Kerschbaumer via Europe PubMed Central
grade
Preferred source (of 2)‎

THE EFFECTS OF STRUCTURAL DAMAGE ON FUNCTIONAL DISABILITY IN PSORIATIC ARTHRITIS

Annals of the Rheumatic Diseases
2017 | Journal article
DOI: 10.1136/ANNRHEUMDIS-2017-EULAR.2835
WOSUID: WOS:000413181401382
Contributors: Kerschbaumer, A.; Alasti, F.; Smolen, J. S.; Aletaha, D.
Source: check_circle
Web of Science Researcher Profile Sync

The effects of structural damage on functional disability in psoriatic arthritis.

Annals of the rheumatic diseases
2017-08 | Journal article
DOI: 10.1136/annrheumdis-2017-211433
PMID: 28835465
Contributors: Kerschbaumer A; Baker D; Smolen JS; Aletaha D
Source: Self-asserted source
Andreas Kerschbaumer via Europe PubMed Central
grade
Preferred source (of 2)‎

The Case | Myeloid bodies in the kidney biopsy of a patient with systemic lupus erythematosus.

Kidney international
2017-07 | Journal article
DOI: 10.1016/j.kint.2016.12.025
PMID: 28647000
Contributors: Bojic M; Kozakowski N; Bécède M; Kerschbaumer A; Bobacz K
Source: Self-asserted source
Andreas Kerschbaumer via Europe PubMed Central
grade
Preferred source (of 2)‎
Items per page:
Page 1 of 2
How many people are using ORCID?